<SEC-DOCUMENT>0001477932-25-008713.txt : 20251201
<SEC-HEADER>0001477932-25-008713.hdr.sgml : 20251201
<ACCEPTANCE-DATETIME>20251201165003
ACCESSION NUMBER:		0001477932-25-008713
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20251126
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251201
DATE AS OF CHANGE:		20251201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UPEXI, INC.
		CENTRAL INDEX KEY:			0001775194
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				833378978
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40535
		FILM NUMBER:		251540342

	BUSINESS ADDRESS:	
		STREET 1:		3030 ROCKY POINT DRIVE
		STREET 2:		SUITE 420
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33607
		BUSINESS PHONE:		701-353-5425

	MAIL ADDRESS:	
		STREET 1:		3030 ROCKY POINT DRIVE
		STREET 2:		SUITE 420
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GROVE, INC.
		DATE OF NAME CHANGE:	20190429
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>upxi_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:upxi="http://upxi.com/20251126"><head><title>upxi_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:left;font:10pt times new roman"><div style="display:none;text-align:left;font:10pt times new roman;margin:0px 7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2025-11-26to2025-11-26" id="ixv-406">0001775194</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2025-11-26to2025-11-26" format="ixt:booleanfalse" id="ixv-407">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="upxi-20251126.xsd"/></ix:references><ix:resources><xbrli:context id="From2025-11-26to2025-11-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001775194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-26</xbrli:startDate><xbrli:endDate>2025-11-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2025-11-26to2025-11-26" id="ixv-427">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>PURSUANT TO SECTION 13 OR 15(D) OF THE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES EXCHANGE ACT OF 1934</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2025-11-26to2025-11-26" format="ixt:datemonthdayyearen" id="ixv-428">November 26, 2025</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:50%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2025-11-26to2025-11-26" id="ixv-429">UPEXI, INC.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact Name of Registrant as Specified in Its Charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2025-11-26to2025-11-26" format="ixt-sec:stateprovnameen" id="ixv-430">Delaware</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityFileNumber" contextRef="From2025-11-26to2025-11-26" id="ixv-431">001-40535</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2025-11-26to2025-11-26" id="ixv-432">83-3378978</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or Other Jurisdiction</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">of Incorporation)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">File Number)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(IRS Employer</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Identification No.)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2025-11-26to2025-11-26" id="ixv-433">3030 N. Rocky Point Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="From2025-11-26to2025-11-26" id="ixv-434">Suite 240</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2025-11-26to2025-11-26" id="ixv-435">Tampa</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2025-11-26to2025-11-26" format="ixt-sec:stateprovnameen" id="ixv-436">Florida</ix:nonNumeric></strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2025-11-26to2025-11-26" id="ixv-437">33607</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of Principal Executive Offices)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Zip Code)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="From2025-11-26to2025-11-26" id="ixv-438">701</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2025-11-26to2025-11-26" id="ixv-439">353-5425</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Registrant&#8217;s Telephone Number, Including Area Code)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<em>see</em> General Instruction A.2. below):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="From2025-11-26to2025-11-26" format="ixt-sec:boolballotbox" id="ixv-440">&#9744;</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="From2025-11-26to2025-11-26" format="ixt-sec:boolballotbox" id="ixv-441">&#9744;</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="From2025-11-26to2025-11-26" format="ixt-sec:boolballotbox" id="ixv-442">&#9744;</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="From2025-11-26to2025-11-26" format="ixt-sec:boolballotbox" id="ixv-443">&#9744;</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Securities registered pursuant to Section 12(b) of the Act:</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Title of each class</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Trading Symbol(s)</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name of each exchange on which registered</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="From2025-11-26to2025-11-26" id="ixv-444">Common Stock, par value $0.00001 per share</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="From2025-11-26to2025-11-26" id="ixv-445">UPXI</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric name="dei:SecurityExchangeName" contextRef="From2025-11-26to2025-11-26" format="ixt-sec:exchnameen" id="ixv-446">Nasdaq</ix:nonNumeric> Stock Market, LLC</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2025-11-26to2025-11-26" format="ixt-sec:boolballotbox" id="ixv-447">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 1.01</strong> <strong>Entry into a Material Definitive Agreement.</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Securities Purchase Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">On November 26, 2025, Upexi, Inc., a Delaware corporation (the &#8220;Company&#8221;), entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with a certain institutional &#160;investor (the &#8220;Purchaser&#8221;) pursuant to which the Company agreed to sell and issue to the Purchaser in a private placement offering (the &#8220;Offering&#8221;): (i) 3,289,474 shares of common stock (the &#8220;Shares&#8221;), par value $0.00001 per share (the &#8220;Common Stock&#8221;), and (ii) common stock purchase warrants (the &#8220;Warrants&#8221;) to purchase up to 3,289,474 shares of Common Stock (the &#8220;Warrant Shares&#8221;) for an aggregate purchase price of $10,000,000, representing a purchase price of $3.04 per share of Common Stock and accompanying Warrant. Each Warrant is exercisable for one share of Common Stock at an exercise price of $4.00 per Warrant Share. The Warrants are immediately exercisable, and may be exercised at any time until all of the Warrants issued in the Offering are exercised in full. The Company intends to use the net proceeds from the Offering for working capital, general corporate purposes and internally managed, Solana (SOL) maximum return strategy. A.G.P/Alliance Global Partners (&#8220;A.G.P&#8221; or the &#8220;Placement Agent&#8221;) acted as the sole placement agent in connection with the Offering. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Shares and the Warrants were offered and sold pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Pursuant to the Purchase Agreement, for a period of 15 days after the effective date of the Resale Registration Statement (as defined below), the Company agreed not to (i) issue, enter into any agreement to issue, or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock equivalents, excluding any agreement related to an equity line of credit where the Placement Agent shall act as placement agent for such equity line (the &#8220;ELOC&#8221;) or (ii) file any registration statement or any amendment or supplement thereto, subject to certain customary exceptions, without the consent of the Purchaser and A.G.P. However, the Company shall be permitted to file (i) a registration statement on Form S-8 with respect to a shareholder approved equity incentive plan, (ii) a universal shelf registration statement on Form S-3, (iii) the Resale Registration Statement, and (iv) any registration statement or prospectus supplement related the ELOC.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Additionally, pursuant to the Purchase Agreement, the Company agreed to file a registration statement (the &#8220;Resale Registration Statement&#8221;) providing for the resale of the Shares and the Warrant Shares within 5 calendar days of the date of the Purchase Agreement, to have the Resale Registration Statement declared effective within 30 days following the filing date (or 60 days, if the Securities and Exchange Commission conducts a full review), and to maintain the effectiveness of the Resale Registration Statement until the Purchaser owns no Warrants or Warrant Shares.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The closing of the Offering occurred on December 1, 2025. The Company received gross proceeds of approximately $10 million from the Offering and may receive up to an additional $13 million upon the cash exercise of the Warrants, if any, before deducting Placement Agent fees and other estimated offering expenses payable by the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Placement Agency Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company also entered into a Placement Agency Agreement (the &#8220;Placement Agency Agreement&#8221;) with A.G.P., dated November 26, 2025, pursuant to which A.G.P agreed to serve as the exclusive placement agent for the Company in connection with the Offering. The Company agreed to pay A.G.P a cash fee equal to 5.0% of the gross cash proceeds received in the Offering. The Company also agreed to pay A.G.P. a cash fee of 5.0% of the aggregate gross proceeds raised from the exercise of the Warrants, if any. In addition, the Company agreed to reimburse A.G.P for up to $75,000 of its legal fees and other out-of-pocket expenses in connection with the Offering, as well as non-accountable expenses incurred by A.G.P for up to $25,000 in connection with the Offering. Pursuant to the Placement Agency Agreement, without the prior written consent of the Purchaser, the Company shall be subject to certain securities issuance restrictions as set forth in the Purchase Agreement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Placement Agency Agreement contains customary representations, warranties, and agreements by the Company, customary conditions to closing, indemnification obligations by the Company, other obligations of the parties, and termination provisions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Lock-Up Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">In addition, each of the Company&#8217;s directors and executive officers entered into a lock-up agreement (the &#8220;Lock-Up Agreement&#8221;), which prohibits them from offering, pledging, announcing the intention to sell, selling, contracting to sell, granting any option or right to purchase, or otherwise transferring or disposing of their shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock for a period of 20 days following the Closing Date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The foregoing summaries of the Warrants, the Purchase Agreement, the Placement Agency Agreement, and the Lock-Up Agreement do not purport to be complete and are qualified in their entirety by reference to the complete text of such agreements, which are attached hereto as Exhibits 4.1, 10.1, 10.2, and 10.3 respectively, to this Current Report on Form 8-K and are hereby incorporated by reference into this Item 1.01.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 3.02</strong> <strong>Unregistered Sale of Equity Securities.</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The information contained above in Item 1.01 relating to the issuance of the Shares and the Warrant Shares is hereby incorporated by reference into this Item 3.02.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Neither this Current Report on Form 8-K nor any exhibit attached hereto constitutes an offer to sell or the solicitation of an offer to buy any securities of the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 8.01</strong> <strong>Other Events.</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">On November 26, 2025, the Company issued a press release announcing the Offering. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 8.01 by reference.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 9.01</strong> <strong>Financial Statements and Exhibits</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(a) Exhibits </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Number</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Description</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex101.htm">4.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex101.htm">Form of&#160;Common Stock Purchase Warrant</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex101.htm">10.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex101.htm">Form of Securities Purchase Agreement, dated as of November 26, 2025, between Upexi, Inc. and the Purchaser (as defined therein)</a></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex102.htm">10.2</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex102.htm">Placement Agency Agreement, dated November 26, 2025, between Upexi, Inc. and A.G.P/Alliance Global Partners</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex103.htm">10.3</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex103.htm">Form of Lock-Up Agreement</a></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex991.htm">99.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="upxi_ex991.htm">Press Release dated November 26, 2025</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">104</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>UPEXI, INC.</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Date: December 1, 2025</p></td><td style="width:3%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td><td style="BORDER-BOTTOM: 1px solid;width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Andrew Norstrud</em></p></td><td style="width:12%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Name:</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Andrew Norstrud</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Title:</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Financial Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>upxi_ex41.htm
<DESCRIPTION>COMMON STOCK PURCHASE WARRANT
<TEXT>
<html><head><title>upxi_ex41.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="margin:0px">&nbsp; </p> <p style="MARGIN: 0px; text-align:right;"><strong>EXHIBIT 4.1&nbsp;</strong></p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&nbsp;&nbsp;THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.&nbsp;</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>COMMON STOCK PURCHASE WARRANT</strong></p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>UPEXI, INC.</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px">Warrant Shares: 3,289,474</p></td> <td> <p style="text-align:right;margin:0px">Issue Date: November [*], 2025</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">THIS COMMON STOCK PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, __________&nbsp;&nbsp;or its assigns (the &#8220;<u>Holder</u>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date set forth above (the &#8220;<u>Initial Exercise Date</u>&#8221;) and on or prior to 5:00 p.m. (New York City time) on November [*], 2029<sup style="vertical-align:super">1</sup>&nbsp;(the &#8220;<u>Termination Date</u>&#8221;), but not thereafter, to subscribe for and purchase from Upexi, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), up to 3,289,474 shares (as subject to adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 1</u>. <u>Definitions</u>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;<u>Purchase Agreement</u>&#8221;), dated November 26, 2025, among the Company and the Holder.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 2</u>. <u>Exercise</u>.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">a) <u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF or Docusign copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <strong>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</strong></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">b) <u>Exercise Price</u>. The exercise price per share of Common Stock under this Warrant shall be $4.00, subject to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">c) <u>Cashless Exercise</u>. If at the time of exercise hereof there is no effective registration statement registering, or no current prospectus is available for, the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 99pt; text-align:justify;">(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&#8220;<u>Bloomberg</u>&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.5in; text-align:justify;">(B) = the Exercise Price of this Warrant, as adjusted hereunder; and</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 104pt; text-align:justify;">(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section 2(c).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company.&nbsp;</p> <p style="margin:0px">_____________________________&nbsp;</p> <p style="margin:0px"><sup style="vertical-align:super">1 </sup>four years from Initial Exercise Date. &nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">d)</p></td> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0.25in"><u style="text-underline: black">Mechanics of Exercise</u>.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 81pt; TEXT-INDENT: 0.5in; text-align:justify;">i. <u>Delivery of Warrant Shares Upon Exercise</u>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;<u>Warrant Share Delivery Date</u>&#8221;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or the Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver, or cause to be delivered, the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 99pt; TEXT-INDENT: 0.5in; text-align:justify;">ii. <u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 99pt; TEXT-INDENT: 0.5in; text-align:justify;">iii. <u>Rescission Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 99pt; TEXT-INDENT: 0.5in; text-align:justify;">iv. <u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 99pt; TEXT-INDENT: 0.5in; text-align:justify;">v. <u>No Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 99pt; TEXT-INDENT: 0.5in; text-align:justify;">vi. <u>Charges, Taxes and Expenses</u>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <u>provided</u>, <u>however</u>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 99pt; TEXT-INDENT: 0.5in; text-align:justify;">vii. <u>Closing of Books</u>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0.5in; text-align:justify;">e) <u>Holder&#8217;s Exercise Limitations</u>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 3</u>. <u>Certain Adjustments</u>.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">a) <u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#8209;classification.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">b) <u>Subsequent Rights Offerings</u>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<u>provided</u>, <u>however</u>, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">c) <u>Pro Rata Distributions</u>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<u>provided</u>, <u>however</u>, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">d) <a name="_Hlk215010281"><u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change the Company&#8217;s name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) or 50% or more of the voting power of the common equity of the Company (each a &#8220;<u>Fundamental Transaction</u>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Warrant Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &#8220;<u>Black Scholes Value</u>&#8221; means the value of this Warrant based on the Black Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day of the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&#8217;s request pursuant to this section 3(d), (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five (5) Trading Days of the Holder&#8217;s election (or, if later, on the effective date of the Fundamental Transaction). The Company shall not effect any Fundamental Transaction in which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless (i) the Alternate Consideration is solely cash and the Company provides for the simultaneous &#8220;cashless exercise&#8221; of this Warrant pursuant to Section 2(c) above or (ii) prior to or simultaneously with the consummation thereof, any successor to the Company, surviving entity or other Person, including any purchaser of assets of the Company (the &#8220;<u>Successor Entity</u>&#8221;), shall assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant. The Company shall cause Successor Entity to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &#8220;Company&#8221; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &#8220;Company&#8221; shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. The provisions of this paragraph (d) shall similarly apply to subsequent transactions analogous to a Fundamental Transaction type.</a></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">e) <u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">f) <u>Notice to Holder</u>.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.25in; TEXT-INDENT: 0.5in; text-align:justify;">i. <u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.25in; TEXT-INDENT: 0.5in; text-align:justify;">ii. <u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">g) <u>Voluntary Adjustment By Company</u>. The Company may at any time during the term of this Warrant, with the prior written consent of the Holder, reduce the then current Exercise Price to any amount for any period of time deemed appropriate by the Board of Directors of the Company unless such reduction would result in the Company violating any rules of its principal Trading Market.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 4</u>. <u>Transfer of Warrant</u>.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">a) <u>Transferability</u>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">b) <u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">c) <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant Register</u>&#8221;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">d) <u>Transfer Restrictions</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">e) <u>Representation by the Holder</u>.&nbsp;&nbsp;The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px;text-indent:0.5in"><u>Section 5. </u>&nbsp;<u>Redemption Right</u>.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">(a) Notwithstanding anything herein to the contrary, this Warrant may be redeemed at the option of the Company in whole or in part on a&nbsp;<em>pro-rata</em>&nbsp;basis, upon the closing price of the Common Stock on the Trading Market on which it is then traded has equaled or exceeded $8.50 per share for ten (10)&nbsp;consecutive Trading Days (the &#8220;<u>Redemption Condition</u>&#8221;). The Company shall provide prompt notice to the Holder upon meeting of the Redemption Condition as provided in Section&nbsp;6(h) below (the &#8220;<u>Notice</u>&#8221;). Following or concurrent with the delivery of the Notice, the Company may, at its option, notify the Holder of its election to redeem the Warrants (the &#8220;<u>Redemption Notice</u>&#8221;), which Redemption Notice shall be delivered no less than 30 calendar days prior to the Redemption Date (as defined below).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">(b) The price at which Warrants may be redeemed (the &#8220;<u>Redemption Price</u>&#8221;) is $[0.0001] per Warrant. On and after the date upon which the Warrants are redeemed by the Company (the &#8220;<u>Redemption Date</u>&#8221;), the Holders of redeemed Warrants shall have no further rights pursuant to the Warrants except to receive payment of the Redemption Price upon surrender of the Warrant Certificates of such redeemed Warrants to the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">(c) Following the delivery of the Notice, if the Company elects to redeem this Warrant, the Company shall promptly send the Redemption Notice to the Holder of Warrants (i)&nbsp;notifying the Holders of such redemption via publication of a press release and (ii)&nbsp;taking such other steps as may be required under applicable law. Notwithstanding any provision to the contrary herein, Warrants noticed for redemption may not be exercised at any time after the 30th calendar day following the date on which the notice of redemption shall have been given by the Company and prior to the Redemption Date unless the Company defaults on payment of the Redemption Price on the Redemption Date.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">(d) From and after the Redemption Date, all Warrants noticed for redemption that have not theretofore been exercised by the Holder shall, upon payment of the aggregate Redemption Price therefor, cease to represent the right to purchase any shares of Common Stock and shall be deemed cancelled and void and of no further force or effect without any further act or deed on the part of the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">(e) The Holder undertakes to return the certificate representing any redeemed Warrants to the Company upon their redemption and to indemnify the Company with respect to any losses, claims, damages or liabilities arising from the Holder&#8217;s failure to return such certificate. In the event the certificate so returned represents a number of Warrants in excess of the number being redeemed, the Company shall as promptly as practicable issue to the Holder a new certificate in book-entry form for the number of unredeemed Warrants.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 6</u>. <u>Miscellaneous</u>.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">a) <u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise&#8221; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company is for any reason unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof, shall the Company be required to net cash settle an exercise of this Warrant or cash settle in any other form.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">b) <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">c) <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">d) <u>Authorized Shares</u>.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0.75in; text-align:justify;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0.5in; text-align:justify;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0.5in; text-align:justify;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">e) <u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">f) <u>Restrictions</u>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">g) <u>Nonwaiver and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">h) <u>Notices</u>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">i) <u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">j) <u>Remedies</u>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">k) <u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">l) <u>Amendment</u>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">m) <u>Severability</u>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">n) <u>Headings</u>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">********************</p> <p style="MARGIN: 0px; text-align:center;"><em>(Signature Page Follows)</em></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:56%;"> <p style="margin:0px">&nbsp;</p></td> <td colspan="2" style="width:7%;vertical-align:top;"> <p style="margin:0px"><strong>UPEXI, INC.</strong></p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:56%;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:56%;"> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;" colspan="2"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:56%;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="margin:0px">Name:</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:56%;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="margin:0px">Title:</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>NOTICE OF EXERCISE</strong></p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">TO: UPEXI, INC.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">(2) Payment shall take the form of (check applicable box):</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.5in; text-align:justify;">&#9744; in lawful money of the United States; or</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.5in; text-align:justify;">&#9744; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">The Warrant Shares shall be delivered to the following DWAC Account Number:</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4)&nbsp;&nbsp;<u>Accredited Investor</u>.&nbsp;&nbsp;The undersigned is an &#8220;accredited investor&#8221; as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">[SIGNATURE OF HOLDER]</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px">Name of Investing Entity:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px"><em>Signature of Authorized Signatory of Investing Entity</em>: </p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px">Name of Authorized Signatory:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">Title of Authorized Signatory:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px">Date:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 9pt; text-align:right;"><strong>EXHIBIT B</strong></p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">ASSIGNMENT FORM</p> <p style="MARGIN: 0px; TEXT-INDENT: 11pt; text-align:justify;"><em>(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</em></p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 11pt; text-align:justify;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">Name:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">(Please Print)</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">Address:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">(Please Print)</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">Phone Number:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="margin:0px">Email Address:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">Dated: _______________ __, ______</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">Holder&#8217;s Signature: _______________</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">Holder&#8217;s Address:_______________</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>upxi_ex101.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT
<TEXT>
<html><head><title>upxi_ex101.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="margin:0px">&nbsp; </p> <p style="MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.1</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>SECURITIES PURCHASE AGREEMENT</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">This Securities Purchase Agreement (this &#8220;<u>Agreement</u>&#8221;) is dated as of November 26, 2025, between Upexi, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#8220;<u>Purchaser</u>&#8221; and collectively, the &#8220;<u>Purchasers</u>&#8221;).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;<u>Securities Act</u>&#8221;), and Rule 506(b) of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</p> <p style="MARGIN: 0px; text-align:center;"><strong>&nbsp; <p style="MARGIN: 0px; text-align:center;">ARTICLE I.&nbsp;</p></strong> <p style="MARGIN: 0px; text-align:center;"><strong>DEFINITIONS</strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">1.1 <u>Definitions</u>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Acquiring Person</u>&#8221; shall have the meaning ascribed to such term in Section 4.5.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Action</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(j).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Board of Directors</u>&#8221; means the board of directors of the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Business Day</u>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally are open for use by customers on such day.</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Closing</u>&#8221; means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Closing Date</u>&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&#8217; obligations to pay the Subscription Amount and (ii) the Company&#8217;s obligations to deliver the Securities, in each case, have been satisfied or waived.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Common Stock</u>&#8221; means the common stock of the Company, par value $0.00001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Common Stock Equivalents</u>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Common Warrants</u>&#8221; means the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, in substantially the form of <u>Exhibit C</u> attached hereto.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Common Warrant Shares</u>&#8221; means the shares of Common Stock issuable upon exercise of the Common Warrants.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Company Counsel</u>&#8221; means Lucosky Brookman LLP, with offices located at 101 Wood Avenue South, 5th Floor, Woodbridge, NJ 08830 United States.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Disclosure Schedules</u>&#8221; means the Disclosure Schedules of the Company delivered concurrently herewith.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Disclosure Time</u>&#8221; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Effective Date</u>&#8221; means the earliest of the date that (a) the initial Registration Statement registering for resale all Shares and Warrant Shares has been declared effective by the Commission, (b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information requirement of Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date provided that a holder of Shares or Warrant Shares is not an Affiliate of the Company, or (d) all of the Shares and Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Evaluation Date</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(s).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Exempt Issuance</u>&#8221; means the issuance (a) of shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) of securities upon the exercise or exchange or conversion of any Securities issued hereunder and/or securities (including options, rights or warrants) exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, (c) of shares of Common Stock issuable pursuant to an equity line of credit whereby the Placement Agent shall act as placement agent for such equity line (the &#8220;<u>ELOC</u>&#8221;), (d) of shares of Common Stock issuable pursuant to an at-the-market facility entered into with the Placement Agent; (e) any convertible debentures, excluding those involving a Variable Rate Transaction, and (f) of securities pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.11 herein, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>FCPA</u>&#8221; means the Foreign Corrupt Practices Act of 1977, as amended.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>GAAP</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Indebtedness</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(bb).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Intellectual Property Rights</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(p).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Legend Removal Date</u>&#8221; shall have the meaning ascribed to such term in Section 4.1(c).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Liens</u>&#8221; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Lock-Up Agreement</u>&#8221; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and executive officers, in the form of <u>Exhibit A</u> attached hereto.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Material Adverse Effect</u>&#8221; shall have the meaning assigned to such term in Section 3.1(b).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Material Permits</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(n).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Per Share Purchase Price</u>&#8221; equals $3.04, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per Pre-Funded Warrant shall be the Per Share Purchase Price minus Pre-Funded Warrant exercise price of $0.00001.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Person</u>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Placement Agent</u>&#8221; means A.G.P./Alliance Global Partners.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Pre-Funded Warrants</u>&#8221; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, in the form of <u>Exhibit B</u> attached hereto.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Pre-Funded Warrant Shares</u>&#8221; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Proceeding</u>&#8221; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Public Information Failure</u>&#8221; shall have the meaning ascribed to such term in Section 4.2(b).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Public Information Failure Payments</u>&#8221; shall have the meaning ascribed to such term in Section 4.2(b).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Purchaser Party</u>&#8221; shall have the meaning ascribed to such term in Section 4.8.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Registration Statement</u>&#8221; shall have the meaning ascribed to such term in Section 4.18.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Required Approvals</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(e).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Rule 144</u>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Rule 424</u>&#8221; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>SEC Reports</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Securities</u>&#8221; means the Shares, the Warrants and the Warrant Shares.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Shares</u>&#8221; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Short Sales</u>&#8221; means all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock). </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Subscription Amount</u>&#8221; means, as to each Purchaser, the aggregate amount to be paid for Shares or Pre-Funded Warrants (in lieu of Shares) and Common Warrants purchased hereunder as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221; in U.S. dollars and in immediately available funds (minus, if applicable, a Purchaser&#8217;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Subsidiary</u>&#8221; means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Trading Market</u>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Transaction Documents</u>&#8221; means this Agreement, the Lock-Up Agreement, the Warrants, and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Transfer Agent</u>&#8221; means VStock Transfer, with a mailing address of 18 Lafayette Place, Woodmere, NY 11598, and any successor transfer agent of the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Variable Rate Transaction</u>&#8221; means a transaction in which the Company issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the Common Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security (other than in connection with a stock split or stock dividend or similar event) or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Warrants</u>&#8221; means, collectively, the Common Warrants and the Pre-Funded Warrants. </p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Warrant Shares</u>&#8221; means, collectively, the Common Warrant Shares and the Pre-Funded Warrant Shares. </p> <p style="margin:0px">&nbsp;</p><strong> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">ARTICLE II.&nbsp; </p></strong> <p style="MARGIN: 0px; text-align:center;"><strong>PURCHASE AND SALE</strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">2.1 <u>Closing</u>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of approximately $10 million of Shares and Common Warrants; provided, however, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser&#8217;s Subscription Amount (together with such Purchaser&#8217;s Affiliates and any Person acting as a group together with such Purchaser or any of such Purchaser&#8217;s Affiliates) would cause such Purchaser&#8217;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares as determined pursuant to Section 2.2(a). The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. In no event may the Beneficial Ownership Limitation exceed 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of the Pre-Funded Warrant held by the Purchaser. In each case, the election to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser shall deliver to the Company, via wire transfer, immediately available funds equal to such Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Shares, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of the Placement Agent or such other location as the parties shall mutually agree. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">2.2 <u>Deliveries</u>.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(a) On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(i) this Agreement duly executed by the Company;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ii) a legal opinion of Company Counsel, in a form reasonably acceptable to the Placement Agent and Purchasers;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(iii) a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, in book entry form (unless otherwise requested by the Purchasers) a number of Shares equal to such Purchaser&#8217;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(iv) the Company&#8217;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">(v) an originally signed Common Warrant registered in the name of such Purchaser to purchase up to the number of shares of Common Stock equal to 100% of such Purchaser&#8217;s Shares plus the Pre-Funded Warrant Shares underlying such Purchaser&#8217;s Pre-Funded Warrant on the date hereof, with an exercise price equal to $4.00, subject to adjustment as set forth therein; </p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(vi) for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&#8217;s Subscription Amount applicable to Pre-Funded Warrant divided by the Per Share Purchase Price minus $0.001, with an exercise price equal to $0.001, subject to adjustment therein; </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(vii) the Lock-Up Agreements;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(viii) a certificate executed by the Chief Financial Officer of the Company, in form and substance reasonably satisfactory to the Placement Agent;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ix) a certificate executed by the Chief Executive Officer and Chief Financial Officer of the Company, in form and substance reasonably satisfactory to the Placement Agent; and </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(x) a secretary&#8217;s certificate executed by an officer of the Company, in form and substance reasonably satisfactory to the Placement Agent. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(b) On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(i) this Agreement duly executed by such Purchaser; and</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ii) such Purchaser&#8217;s Subscription Amount by wire transfer to the account specified by the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">2.3 <u>Closing Conditions</u>.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(a) The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate in all material respects (or to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ii) all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(iii) the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(b) The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ii) all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(iii) the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(iv) there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(v) from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&#8217;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><strong> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">ARTICLE III. </p></strong> <p style="MARGIN: 0px; text-align:center;"><strong>REPRESENTATIONS AND WARRANTIES</strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">3.1 <u>Representations and Warranties of the Company</u>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(a) <u>Subsidiaries</u>. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports or have otherwise been disclosed to Purchasers by the Company. The Company owns, directly or indirectly, all of its capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(b) <u>Organization and Qualification</u>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#8220;<u>Material Adverse Effect</u>&#8221;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(c) <u>Authorization; Enforcement</u>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&#8217;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(d) <u>No Conflicts</u>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(e) <u>Filings, Consents and Approvals</u>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the notice and/or additional listing application(s) to each applicable Trading Market for the listing of the Shares and the Warrant Shares for trading thereon in the time and manner required thereby; (iii) the Registration Statement; and (iv) the filing of Form D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the &#8220;<u>Required Approvals</u>&#8221;). </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(f) <u>Issuance of the Securities</u>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(g) <u>Capitalization</u>. The capitalization of the Company as of the date hereof is as set forth on <u>Schedule 3.1(g)</u>, which <u>Schedule 3.1(g)</u> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. Except as set forth on <u>Schedule 3.1(g)</u> and as disclosed in the SEC Reports, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth in <u>Schedule 3.1(g)</u> or as a result of the purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or &#8220;phantom stock&#8221; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(h) <u>SEC Reports; Financial Statements</u>. Except as set forth on Schedule 3.1(h), the Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#8220;<u>SEC Reports</u>&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#8220;<u>GAAP</u>&#8221;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(i) <u>Material Changes; Undisclosed Events, Liabilities or Developments</u>. Since the date of the latest audited financial statements included within the SEC Reports, except as set forth in the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(j) <u>Litigation</u>. Except as set forth on <u>Schedule 3.1(j)</u>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#8220;<u>Action</u>&#8221;). None of the Actions set forth on <u>Schedule 3.1(j)</u>, (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(k) <u>Labor Relations</u>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&#8217;s or its Subsidiaries&#8217; employees is a member of a union that relates to such employee&#8217;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(l) <u>Compliance</u>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(m) <u>Environmental Laws</u>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &#8220;<u>Hazardous Materials</u>&#8221;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#8220;<u>Environmental Laws</u>&#8221;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(n) <u>Regulatory Permits</u>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#8220;<u>Material Permits</u>&#8221;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(o) <u>Title to Assets</u>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(p) <u>Intellectual Property</u>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &#8220;<u>Intellectual Property Rights</u>&#8221;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(q) <u>Insurance</u>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(r) <u>Transactions with Affiliates and Employees</u>. Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(s) <u>Sarbanes-Oxley; Internal Accounting Controls</u>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms. The Company&#8217;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#8220;<u>Evaluation Date</u>&#8221;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(t) <u>Certain Fees</u>. Except for the fees and expenses of the Placement Agent as set forth in the Placement Agent Agreement, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(u) <u>Private Placement</u>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(v) <u>Investment Company</u>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities and application of the proceeds as set forth under Section 4.7, will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration under the Investment Company Act of 1940, as amended.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(w) <u>Registration Rights</u>. Other than to each of the Purchasers pursuant to Section 4.18 hereof, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(x) <u>Listing and Maintenance Requirements</u>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as disclosed in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(y) <u>Application of Takeover Protections</u>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&#8217;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&#8217;s issuance of the Securities and the Purchasers&#8217; ownership of the Securities.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(z) <u>Disclosure</u>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents and the representations made in Section 3.1(i), the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(aa) <u>No Integrated Offering</u>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(bb) <u>Indebtedness</u>. <u>Schedule 3.1(bb)</u> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &#8220;<u>Indebtedness</u>&#8221; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable or accrued payroll liabilities incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&#8217;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(cc) <u>Tax Status</u>. The Company and its Subsidiaries each (i) has made or filed all material United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all material taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(dd) <u>No General Solicitation</u>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any form of &#8220;general solicitation&#8221; or &#8220;general advertising&#8221; (as such terms are defined in Regulation D under the Securities Act). The Company has offered the Securities for sale only to the Purchasers and certain other &#8220;accredited investors&#8221; within the meaning of Rule 501(a) of Regulation D under the Securities Act.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ee) <u>Foreign Corrupt Practices</u>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ff) <u>Accountants</u>. The Company&#8217;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&#8217;s Annual Report for the fiscal year ending June 30, 2026.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(gg) <u>No Disagreements with Accountants and Lawyers</u>. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company&#8217;s ability to perform any of its obligations under any of the Transaction Documents.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(hh) <u>Acknowledgment Regarding Purchasers&#8217; Purchase of Securities</u>. The Company acknowledges and agrees that, to its knowledge, each of the Purchasers is acting solely in the capacity of an arm&#8217;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that, to its knowledge, no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#8217; purchase of the Securities. The Company further represents to each Purchaser that the Company&#8217;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ii) <u>Acknowledgment Regarding Purchaser&#8217;s Trading Activity</u>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(i) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &#8220;derivative&#8221; securities based on securities issued by the Company or to hold the Securities for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &#8220;derivative&#8221; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#8217;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &#8220;derivative&#8221; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &#8220;short&#8221; position in the Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&#8217;s length counter-party in any &#8220;derivative&#8221; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&#8217; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(jj) <u>Regulation M Compliance</u>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&#8217;s placement agent in connection with the placement of the Securities.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(kk) <a name="_cp_change_39"><u style="text-underline: blue double">[</u></a>Reserved<a name="_cp_change_40"><u style="text-underline: blue double">]</u></a>.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ll) <a name="_cp_change_41"><u style="text-underline: blue double">[</u></a>Reserved<a name="_cp_change_42"><u style="text-underline: blue double">]</u></a>.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(mm) <u>Stock Option Plans</u>. Each stock option granted by the Company under the Company&#8217;s stock option plan was granted (i) in accordance with the terms of the Company&#8217;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&#8217;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(nn) <u>Office of Foreign Assets Control</u>. Neither the Company nor any Subsidiary nor, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<u>OFAC</u>&#8221;).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(oo) <u>U.S. Real Property Holding Corporation</u>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#8217;s request.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(pp) <u>Bank Holding Company Act</u>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<u>BHCA</u>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<u>Federal Reserve</u>&#8221;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(qq) <u>Money Laundering</u>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;<u>Money Laundering Laws</u>&#8221;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(rr) <u>No Disqualification Events</u>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506(b) of Regulation D under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &#8220;<u>Issuer Covered Person</u>&#8221; and, together, &#8220;<u>Issuer Covered Persons</u>&#8221;) is subject to any of the &#8220;Bad Actor&#8221; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &#8220;<u>Disqualification Event</u>&#8221;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(ss) <u>Other Covered Persons</u>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(tt) <u>Notice of Disqualification Events</u>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">3.2 <u>Representations and Warranties of the Purchasers</u>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>(a) Organization; Authority</u>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(b) <u>Understandings or Arrangements</u>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser understands that the Securities are &#8220;restricted securities&#8221; and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(c) <u>Purchaser Status</u>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants, it will be either: (i) an &#8220;accredited investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act, (ii) a &#8220;qualified purchaser&#8221; as defined in the Securities Act or (iii) a &#8220;qualified institutional buyer&#8221; as defined in Rule 144A(a)(1) under the Securities Act. Such Purchaser hereby represents that neither such Purchaser nor any of its Rule 506(d) Related Parties (as defined below) is a &#8220;bad actor&#8221; within the meaning of Rule 506(d) promulgated under the Securities Act. For purposes of this Agreement, &#8220;<u>Rule 506(d) Related Party</u>&#8221; shall mean a person or entity covered by the &#8220;Bad Actor disqualification&#8221; provision of Rule 506(d) of Regulation D under the Securities Act.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><a name="_Toc166076158"><u>(d)&nbsp; Intent</u></a>. The Purchaser is purchasing the Securities, solely for the Purchaser&#8217;s own account and not for the account of others, and not with a view to the resale or distribution of any part thereof in violation of the Securities Act, and the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same in violation of the Securities Act without prejudice, however, to the Purchaser&#8217;s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable federal and state securities laws.&nbsp; Notwithstanding the foregoing, if the Purchaser is purchasing the Securities as a fiduciary or agent for one or more investor accounts, the Purchaser has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account. The Purchaser has no present arrangement to sell the Securities to or through any person or entity. The Purchaser understands that the Securities must be held indefinitely unless such Securities are resold pursuant to a registration statement under the Securities Act or an exemption from registration is available. Nothing contained herein shall be deemed a representation or warranty by the Purchaser to hold the Securities for any period of time.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(e) <u>Experience of Such Purchaser</u>. The Purchaser acknowledges that it can bear the economic risk and complete loss of its investment in the Securities and has knowledge and experience in finance, securities, taxation, investments and other business matters as to be capable of evaluating the merits and risks of investments of the kind described in this Agreement and contemplated hereby, and the Purchaser has had an opportunity to seek, and has sought, such accounting, legal, business and tax advice as the Purchaser has considered necessary to make an informed investment decision. The Purchaser acknowledges that the Purchaser (i) is a sophisticated investor, experienced in investing in private placements of equity securities and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities and (ii) has exercised independent judgment in evaluating its participation in the purchase of the Securities. The Purchaser acknowledges that the Purchaser is aware that there are substantial risks incident to the purchase and ownership of the Securities, including those set forth in the Company&#8217;s filings with the SEC. Alone, or together with any professional advisor(s), the Purchaser has adequately analyzed and fully considered the risks of an investment in the Securities and determined that the Securities are a suitable investment for the Purchaser. The Purchaser is, at this time and in the foreseeable future, able to afford the loss of the Purchaser&#8217;s entire investment in the Securities and the Purchaser acknowledges specifically that a possibility of total loss exists.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>(f) Independent Investment Decision</u>. The Purchaser understands that nothing in the Transaction Agreements or any other materials presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice. The Purchaser has consulted such legal, tax and investment advisors as it, in such Purchaser&#8217;s sole discretion, has deemed necessary or appropriate in connection with its purchase of the Securities.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(g) <u>General Solicitation</u>. The Purchaser acknowledges and agrees that the Purchaser is purchasing the Securities directly from the Company. Purchaser became aware of this offering of the Securities solely by means of direct contact from the Placement Agents or directly from the Company as a result of a pre-existing, substantive relationship with the Company or the Placement Agents, and/or their respective advisors (including, without limitation, attorneys, accountants, bankers, consultants and financial advisors), agents, control persons, representatives, affiliates, directors, officers, managers, members, and/or employees, and/or the representatives of such persons. The Securities were offered to Purchaser solely by direct contact between Purchaser and the Company, the Placement Agent and/or their respective representatives. Purchaser did not become aware of this offering of the Securities, nor were the Securities offered to Purchaser, by any other means, and none of the Company, the Placement Agents and/or their respective representatives acted as investment advisor, broker or dealer to Purchaser. The Purchaser is not purchasing the Securities as a result of any general or public solicitation or general advertising, or publicly disseminated advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television, radio or the internet or presented at any seminar or any other general solicitation or general advertisement, including any of the methods described in Section 502(c) of Regulation D under the Securities Act. </p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>(h) Risk Factors</u>. The Purchaser understands and acknowledges that his, her or its purchase of the Securities is a speculative investment that involves a high degree of risk and the potential loss of their entire investment and has carefully read and considered the matters and Risk factors set forth in the SEC Reports.<a name="_Toc166076165"></a></p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(i)<u> Certain Trading Activities</u>. Other than consummating the transaction contemplated hereby, the Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with the Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that the Purchaser was first contacted by the Company or any other Person regarding the transaction contemplated hereby and ending immediately prior to the date of this Agreement. Notwithstanding the foregoing, in the case of an Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall only apply with respect to the portion of the assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement and to its advisors and agents who had a need to know such information, the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><a name="_Toc166076166">(j)<u> Disqualification Event</u></a>. To the extent the Purchaser is one of the covered persons identified in Rule 506(d)(1), the Purchaser represents that no Disqualification Event is applicable to the Purchaser or any of its Rule 506(d) Related Parties (as defined below), except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. The Purchaser hereby agrees that it shall notify the Company promptly in writing in the event a Disqualification Event becomes applicable to the Purchaser or any of its Rule 506(d) Related Parties, except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. For purposes of this Section, &#8220;Rule 506(d) Related Party&#8221; means a person or entity that is a beneficial owner of the Purchaser&#8217;s securities for purposes of Rule 506(d) of the Securities Act.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(n) <u>Access to Information</u>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(m) <u>Certain Transactions and Confidentiality</u>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&#8217;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely on the Company&#8217;s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document, or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>ARTICLE IV. <p style="margin:0px"> <p style="margin:0px">OTHER AGREEMENTS OF THE PARTIES</p></strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.1 <u>Transfer Restrictions</u>.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(a) The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration under the Securities Act. As a condition of transfer (other than pursuant to an effective Registration Statement), any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under this Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(b) The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities substantially in the following form:</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#8220;ACCREDITED INVESTOR&#8221; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &#8220;accredited investor&#8221; as defined in Rule 501(a) of Regulation D under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser&#8217;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including, if the Securities are subject to registration pursuant to Section 4.4 of this Agreement, the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling stockholders thereunder.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(c) Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 and the Company is then in compliance with the current public information required under Rule 144, (iii) if such Shares or Warrant Shares are may be sold under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Shares or Warrant Shares and without volume or manner-of-sale restrictions, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Warrant Shares, or if the Shares or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current public information required under Rule 144, or if the Shares or Warrant Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Shares or Warrant Shares or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission), then such Shares or Warrant Shares shall be issued free of all legends. The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder or if reasonably required by a Purchaser. The Company agrees that following the Effective Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend (such date, the &#8220;<u>Legend Removal Date</u>&#8221;), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.1. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&#8217;s prime broker with the Depository Trust Company as directed by such Purchaser. As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend. The Purchaser shall provide the Company written notice of a removal request (the &#8220;<strong>Request Notice</strong>&#8221;) at least two (2) Trading Days prior to delivery of the legended Share certificate.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(d) In addition to such Purchaser&#8217;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date (or, if later, four days after the Request Notice date) until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such Purchaser&#8217;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &#8220;<u>Buy-In Price</u>&#8221;) over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares and ending on the date of such delivery and payment under this clause (ii).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(e) Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company&#8217;s reliance upon this understanding.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.2 <u>Furnishing of Information; Public Information</u>.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(a) For at least two years after the Closing Date, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">(b) At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities of a Purchaser may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &#8220;<u>Public Information Failure</u>&#8221;) then, in addition to such Purchaser&#8217;s other available remedies, the Company shall pay to that Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to $1,000 per day of a Public Information Failure&nbsp; until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required for that Purchaser to transfer the Shares or Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as &#8220;<u>Public Information Failure Payments</u>.&#8221; Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3<sup style="vertical-align:super">rd</sup>) Business Day after the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, other than during the pendency of any bona fide dispute over whether an alleged Public Information Failure has occurred, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&#8217;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.3 <u>Integration</u>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.4 <u>Securities Laws Disclosure; Publicity</u>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with (i) any registration statement contemplated by this Agreement and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.5 <u>Shareholder Rights Plan</u>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#8220;<u>Acquiring Person</u>&#8221; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.6 <u>Non-Public Information</u>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser&#8217;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.7 <u>Use of Proceeds</u>. The Company shall use the net proceeds from the sale of the Securities hereunder for internally managed, Solana (SOL) maximum return strategy and shall not use such proceeds: (a) for the redemption of any Common Stock or Common Stock Equivalents, (b) for the settlement of any outstanding litigation or (c) in violation of FCPA or OFAC regulations. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">21</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.8 <u>Indemnification of Purchasers</u>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees, investment managers and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;<u>Purchaser Party</u>&#8221;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.9 <u>Reservation of Common Stock</u>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares issuable pursuant to any exercise of the Warrants.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.10 <u>Listing of Common Stock</u>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market prior to the Closing and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market prior to Closing. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to maintain the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#8217;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">22</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.11 <a name="_cp_change_50"><u>Subsequent Equity Sales</u>.</a> From the date hereof until fifteen (15) days after the Effective Date, neither the Company nor any Subsidiary shall <a name="_Hlk215008042">(i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, other than (A) a registration statement on Form S-8 with respect to a shareholder approved equity incentive plan, (B) a universal shelf registration statement on Form S-3 to be filed by the Company on or about December 19, 2025, or (B) the Registration Statement; provided, however, the Company will be permitted to file any registration statement or prospectus supplement related to the ELOC as well as enter into any agreement related to the issuance of the ELOC. Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance.</a></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.12 <u>Equal Treatment of Purchasers</u>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.13 <u>Certain Transactions and Confidentiality</u>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company&#8217;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules. Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.14 <u>Form D; Blue Sky Filings</u>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under applicable securities or &#8220;Blue Sky&#8221; laws of the states of the United States and shall provide evidence of such actions promptly upon request of any Purchaser.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.15 <u>Acknowledgment of Dilution</u>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">23</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.16 <u>Exercise Procedures</u>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.<u> </u></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">4.17 <u>Lock-Up Agreements</u>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements without the prior written consent of the Placement Agent, except to extend the term of the lock-up period, and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">4.18 <u>Registration Statement</u>. As soon as practicable (and in any event within five (5)calendar days of this Agreement), the Company shall file a registration statement on Form S-1 (or any other available form) (the &#8220;<u>Registration Statement</u>&#8221;) providing for the resale by the Purchasers of the Shares and the Warrant Shares issued and issuable upon exercise of the Warrants. The Company shall use commercially reasonable efforts to (a) cause the Registration Statement to become effective within thirty (30) days (sixty (60) days in the event the Commission elects to review the Registration Statement) following the filing date of the Registration Statement (the &#8220;<u>Effectiveness Date</u>&#8221;), and (b) keep the Registration Statement effective at all times until no Purchaser owns any Warrants or Warrant Shares issuable upon exercise thereof.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>ARTICLE V. <p style="margin:0px"> <p style="margin:0px">MISCELLANEOUS</p></strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.1 <u>Termination</u>. This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5<sup style="vertical-align:super">th</sup>) Trading Day following the date hereof; <u>provided</u>, <u>however</u>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.2 <u>Fees and Expenses</u>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.3 <u>Entire Agreement</u>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.4 <u>Notices</u>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<sup style="vertical-align:super">nd</sup>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">24</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.5 <u>Amendments; Waivers</u>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial Subscription Amounts hereunder (or, prior to the Closing Date, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.6 <u>Headings</u>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.7 <u>Successors and Assigns</u>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers&#8221; (other than in respect of a transfer pursuant to an effective registration statement).</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.8 <u>Third-Party Beneficiaries</u>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.9 <u>Governing Law</u>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">25</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.10 <u>Survival</u>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for the applicable statute of limitations.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.11 <u>Execution</u>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221; format data file or DocuSign, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; or DocuSign signature page were an original thereof.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.12 <u>Severability</u>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.13 <u>Rescission and Withdrawal Right</u>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; <u>provided</u>, <u>however</u>, that, in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&#8217;s right to acquire such shares pursuant to such Purchaser&#8217;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right). </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.14 <u>Replacement of Securities</u>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.15 <u>Remedies</u>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.16 <u>Payment Set Aside</u>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">26</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.17 <u>Independent Nature of Purchasers&#8217; Obligations and Rights</u>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.18 <u>Liquidated Damages</u>. The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.19 <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.20 <u>Construction</u>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">5.21 <strong><u>WAIVER OF JURY TRIAL</u>. <u>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </u></strong></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">27</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="2" style="vertical-align:top;"> <p style="margin:0px"><strong>Upexi, Inc.</strong></p> <p style="margin:0px">&nbsp;</p></td> <td></td> <td style="vertical-align:top;"> <p style="margin:0px"><u style="text-underline: black">Address for Notice</u>:</p></td></tr> <tr style="height:15px"> <td colspan="2"></td> <td></td> <td></td></tr> <tr style="height:15px"> <td style="width:2%;vertical-align:bottom;"> <p style="margin:0px">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;"><em>&nbsp;/s/ Allan Marshall</em></td> <td style="width:20%;"></td> <td style="width:43%;vertical-align:top;"> <p style="margin:0px">Upexi, Inc.</p></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">Name: Allan Marshall</p></td> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">Attn: Allan Marshall, President and CEO</p></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">Title: President and CEO</p></td> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">3030 North Rocky Point Drive</p> <p style="margin:0px">Tampa, Florida 33607</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td colspan="4" style="vertical-align:top;"> <p style="margin:0px">With a copy to (which shall not constitute notice):</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">Peter Campitiello</p> <p style="margin:0px">Lucosky Brookman LLP</p> <p style="margin:0px">101 Wood Avenue South, 5th Floor</p> <p style="margin:0px">Woodbridge, NJ 08830</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">Email: pcampitiello@lucbro.com</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK SIGNATURE PAGE FOR PURCHASER FOLLOWS]</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">28</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">[PURCHASER SIGNATURE PAGES TO UPEXI, Inc. SECURITIES PURCHASE AGREEMENT]</p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:40%;vertical-align:bottom;"> <p style="margin:0px">Name of Purchaser:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:60%;"></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:bottom;"> <p style="margin:0px"><em>Signature of Authorized Signatory of Purchaser:</em></p></td> <td style="BORDER-BOTTOM: 1px solid;"></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:bottom;"> <p style="margin:0px">Name of Authorized Signatory:</p></td> <td style="BORDER-BOTTOM: 1px solid;"></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:bottom;"> <p style="margin:0px">Title of Authorized Signatory:</p></td> <td style="BORDER-BOTTOM: 1px solid;"></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:bottom;"> <p style="margin:0px">Email Address of Authorized Signatory:</p></td> <td style="BORDER-BOTTOM: 1px solid;"></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:bottom;"> <p style="margin:0px">Address for Notice to Purchaser:</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">&nbsp;</p></td> <td></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">Subscription Amount: $_________________</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">Shares: _________________</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px">Pre-Funded Warrant Shares: _______________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">Warrant Shares: _______________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">EIN Number: _________________</p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">[SIGNATURE PAGES CONTINUE]</p> <p style="margin:0px">&nbsp;</p><strong> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">29</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">Exhibit A</p></strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>Form of Lock Up Agreement</strong></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">See attached. </p> <p style="margin:0px">&nbsp;</p><strong> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">30</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">Exhibit B </p></strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>Form of Pre-Funded Warrant </strong></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">See attached. </p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p><strong> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">31</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">Exhibit C </p></strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>Form of Common Warrant </strong></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">See attached. </p> <p style="margin:0px">&nbsp;</p><strong> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">32</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">UPEXI, INC.</p></strong> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>Disclosure Schedules to Securities Purchase Agreement</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>&nbsp;&nbsp;&nbsp;&nbsp;, 2025</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">33</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>upxi_ex102.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT
<TEXT>
<html><head><title>upxi_ex102.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.2</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0.5in; text-align:right;">November 26, 2025</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Upexi, Inc.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Attn: Allan Marshall, Chief Executive Officer and President</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">3030 North Rocky Point Drive</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Tampa, Florida 33607</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dear Mr. Marshall:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">This letter (the &#8220;<strong>Agreement</strong>&#8221;) constitutes the agreement between A.G.P./Alliance Global Partners (the &#8220;<strong>Placement Agent</strong>&#8221;) and Upexi, Inc., a Delaware corporation (the &#8220;<strong>Company</strong>&#8221;), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a &#8220;reasonable best efforts&#8221; basis, in connection with the proposed placement (the &#8220;<strong>Placement</strong>&#8221;) of shares (the &#8220;<strong>Shares</strong>&#8221;) of the Company&#8217;s common stock, par value $0.00001 per share (the &#8220;<strong>Common Stock</strong>&#8221;), pre-funded Common Stock purchase warrants to purchase shares of Common Stock (the &#8220;<strong>Pre-Funded Warrants</strong>&#8221;) and Common Stock purchase warrants to purchase shares of Common Stock (the &#8220;<strong>Common Warrants</strong>&#8221;). The Common Stock, Pre-Funded Warrants and Comon Warrants actually placed by the Placement Agent are referred to herein as the &#8220;<strong>Placement Agent Securities</strong>.&#8221; The terms of the Placement shall be mutually agreed upon by the Company and the purchaser of the Securities (the &#8220;<strong>Purchaser</strong>&#8221;), and nothing herein constitutes that the Placement Agent would have the power or authority to bind the Company or the Purchaser, or an obligation for the Company to issue any Securities or complete the Placement. The Company expressly acknowledges and agrees that the Placement Agent&#8217;s obligations hereunder are on a reasonable best efforts basis only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of the Placement Agent with respect to securing any other financing on behalf of the Company. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement. Certain affiliates of the Placement Agent may participate in the Placement by purchasing some of the Placement Agent Securities. The sale of Placement Agent Securities to the Purchaser will be evidenced by a securities purchase agreement (the &#8220;<strong>Purchase Agreement</strong>&#8221;) between the Company and such Purchaser, in a form reasonably acceptable to the Company and the Purchaser. Capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company will be available to answer inquiries from the prospective Purchaser.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 1</u>. <u>REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">A. <u>Representations of the Company</u>. With respect to the Placement Agent Securities, each of the representations and warranties (together with any related disclosure schedules thereto) and covenants made by the Company to the Purchaser in the Purchase Agreement in connection with the Placement, are hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that there are no affiliations with any FINRA (as defined below) member firm among the Company&#8217;s officers, directors or, to the knowledge of the Company, any five percent (5.0%) or greater securityholder of the Company, except as set forth in the Purchase Agreement.<strong> </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">B. <u>Covenants of the Company</u>. The Company covenants and agrees to continue to retain (i) a firm of independent PCAOB registered public accountants for a period of at least two (2) years after the Closing Date and (ii) a competent transfer agent with respect to the Common Stock for a period of five (5) years after the Closing Date. Furthermore, except as set forth below, from the date hereof until fifteen (15)days after the Effective Date (the &#8220;<strong>Restriction Period</strong>&#8221;), without the prior written consent of the Placement Agent, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, other than (A) a registration statement on Form S-8 with respect to a shareholder approved equity incentive plan, (B) a universal shelf registration statement on Form S-3 to be filed by the Company on or about December 19, 2025, or (B) the Registration Statement; provided, however, the Company will be permitted to file any registration statement or prospectus supplement related to the ELOC as well as enter into any agreement related to the issuance of the ELOC; provided, however, such restrictions shall not apply with respect to an Exempt Issuance.&nbsp;&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 2</u>. <u>REPRESENTATIONS OF THE PLACEMENT AGENT</u>. The Placement Agent represents and warrants that it (i) is a member in good standing of FINRA, (ii) is registered as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the laws of the United States of America, applicable to the offers and sales of the Placement Agent Securities by the Placement Agent, (iv) is and will be a corporate body validly existing under the laws of its place of incorporation, and (v) has full power and authority to enter into and perform its obligations under this Agreement. The Placement Agent will immediately notify the Company in writing of any change in its status with respect to subsections (i) through (v) above. The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and the requirements of applicable law. The Placement Agent represents and warrants that, to its knowledge after reasonable investigation, each of the Purchasers is a &#8220;qualified purchaser&#8221; within the meaning of the Securities Act, and that the Placement Agent has not engaged in any marketing or sales activity that constitutes a &#8220;general solicitation&#8221; or &#8220;general advertising&#8221; within the meaning of Rule 502(c) under the Securities Act</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 3</u>. <u>COMPENSATION</u>. &nbsp;In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent and/or its respective designees a cash fee of 5.00% of the aggregate gross proceeds raised from the sale of the Placement Agent Securities (the &#8220;<strong>Cash Fee</strong>&#8221;). The Cash Fee shall be paid on the Closing Date. The Company shall also pay to the Placement Agent and/or its respective designees a cash fee of 5.00% of the aggregate gross proceeds raised from the exercise of the Common Warrants (the &#8220;<strong>Warrant Fee</strong>&#8221;). The Warrant Fee shall be paid on each date the Company receives proceeds from the exercise of the Common Warrants. The Company also agrees to reimburse the Placement Agent for accountable legal fees and other out-of-pocket expenses incurred by the Placement Agent in connection with the Placement in an amount not to exceed $75,000, as well as non-accountable expenses (the &#8220;<strong>NAE</strong>&#8221;) including, but not limited to, IPREO software related expenses, background check(s), marketing related expenses; i.e. roadshow, travel, et al. and any other expenses incurred by the Placement Agent in connection with the Placement (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement). The total NAE allowances shall not exceed $25,000. The Placement Agent will provide an accounting of legal and out-of-pocket expenses and NAE prior to payment. The Placement Agent reserves the right to reduce any item of compensation, including the reimbursement of expenses, or adjust the terms thereof as specified herein in the event that a determination shall be made by FINRA to the effect that the Placement Agent&#8217;s aggregate compensation is in excess of FINRA Rules or that the terms thereof require adjustment.&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 4</u>. <u>INDEMNIFICATION</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">A. To the extent permitted by law, with respect to the Placement Agent Securities, the Company will indemnify the Placement Agent and its affiliates, stockholders, directors, officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to this Agreement, except to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly from the Placement Agent&#8217;s fraud, willful misconduct or gross negligence in performing the services described herein.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">B. Promptly after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which the Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or of the commencement of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any obligation it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial rights and defenses. If the Company so elects or is requested by the Placement Agent, the Company will assume the defense of such action or proceeding and will employ counsel reasonably satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding the preceding sentence, the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from any other party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable rules of professional responsibility for the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable fees and disbursements of no more than one (1) such separate counsel will be paid by the Company, in addition to fees of local counsel. The Company will have the right to settle the claim or proceeding provided that the Company will not settle any such claim, action or proceeding without the prior written consent of the Placement Agent, which will not be unreasonably withheld. The Company shall not be liable for any settlement of any action effected without its written consent, which will not be unreasonably withheld.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">C. The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement of any action or proceeding relating to a transaction contemplated by this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">D. If for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless, then the Company shall contribute to the amount paid or payable by the Placement Agent as a result of such losses, claims, damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one hand and the Placement Agent on the other, but also the relative fault of the Company on the one hand and the Placement Agent on the other that resulted in such losses, claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable by a party in respect of losses, claims, damages and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the Placement Agent&#8217;s share of the liability hereunder shall not be in excess of the amount of fees actually received, or to be received, by the Placement Agent under this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">E. These indemnification provisions shall remain in full force and effect whether or not the transaction contemplated by this Agreement is completed and shall survive the termination of this Agreement, and shall be in addition to any liability that the Company might otherwise have to any indemnified party under this Agreement or otherwise.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 5</u>. <u>ENGAGEMENT TERM</u>. The Placement Agent&#8217;s engagement hereunder will commence on the date hereof and terminate on the sooner of the Closing Date or ten (10) days from the date hereof. The date of termination of this Agreement is referred to herein as the &#8220;<strong>Termination Date</strong>.&#8221; In the event, however, in the course of the Placement Agent&#8217;s performance of due diligence it deems it necessary to terminate the engagement, the Placement Agent may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason prior to the Termination Date but will remain responsible for fees and expenses pursuant to Section 3 hereof and fees and expenses with respect to the Placement Agent Securities, if sold in the Placement. Notwithstanding anything to the contrary contained herein, the provisions concerning the Company&#8217;s obligation to pay any fees or expenses actually earned pursuant to Section 3 hereof and the provisions concerning confidentiality, indemnification and contribution contained herein will survive any expiration or termination of this Agreement. If this Agreement is terminated prior to the completion of the Placement, all fees or expenses due to the Placement Agent shall be paid by the Company to the Placement Agent on or before the Termination Date (in the event such fees or expenses are earned or owed as of the Termination Date). The Placement Agent agrees not to use any confidential information concerning the Company provided to the Placement Agent by the Company for any purposes other than those contemplated under this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 6 PLACEMENT AGENT INFORMATION</u>. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement is for the confidential use of the Company only in its evaluation of the Placement and, except as otherwise required by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&#8217;s prior written consent.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 7</u>. <u>NO FIDUCIARY RELATIONSHIP</u>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person or entity not a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement Agent hereunder, all of which are hereby expressly waived.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 8</u>. <u>CLOSING</u>. The obligations of the Placement Agent, and the closing of the sale of the Placement Agent Securities hereunder are subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company contained herein and in the Purchase Agreement, to the performance by the Company of its obligations hereunder and in the Purchase Agreement, and to each of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">A. All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement, the Placement Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby with respect to the Placement Agent Securities shall be reasonably satisfactory in all material respects to the Placement Agent.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">B. The Placement Agent shall have received a legal opinion of Company Counsel, in a form reasonably acceptable to the Placement Agent, with respect to the Placement Agent Securities, addressed to the Placement Agent and dated as of the Closing Date. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">C. The Placement Agent shall have received a certificate executed by the Chief Financial Officer of the Company, in form and substance reasonably satisfactory to the Placement Agent.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">D. The Placement Agent shall have received a certificate executed by the Chief Executive Officer and Chief Financial Officer of the Company, in form and substance reasonably satisfactory to the Placement Agent.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">E. The Placement Agent shall have received a secretary&#8217;s certificate executed by an officer of the Company, in form and substance reasonably satisfactory to the Placement Agent.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">F. The Common Stock shall be registered under the Exchange Act in accordance with the terms of the Purchase Agreement and, as of the Closing Date, the Shares and shares of Common Stock issuable upon exercise of the Pre-Funded Warrants and Common Warrants shall be listed and admitted and authorized for trading on the Trading Market or other applicable U.S. national exchange and satisfactory evidence of such action shall have been provided to the Placement Agent. The Company shall have taken no action designed to, or likely to have the effect of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or other applicable U.S. national exchange, nor has the Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">G. No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would, as of the Closing Date, prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">H. The Company shall have entered into a Purchase Agreement with the Purchasers of the Placement Agent Securities and such agreement shall be in full force and effect and shall contain representations, warranties and covenants of the Company as agreed upon between the Company and the Purchasers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 1in; text-align:justify;">I. FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company shall, if requested by the Placement Agent, make or authorize Placement Agent&#8217;s counsel to make on the Company&#8217;s behalf, any necessary filing with the FINRA Corporate Financing Department with respect to the Placement and pay all filing fees required in connection therewith.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">If any of the conditions specified in this Section 8 shall not have been fulfilled when and as required by this Agreement, all obligations of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 9</u>. <u>GOVERNING LAW</u>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements made and to be performed entirely in such State, without regard to its conflict of laws principles. This Agreement may not be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&#8217;s fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 10</u>. <u>ENTIRE AGREEMENT/MISCELLANEOUS</u>. This Agreement embodies the entire agreement and understanding between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except by an instrument in writing signed by both the Placement Agent and the Company. The representations, warranties, agreements and covenants contained herein shall survive the Closing Dates of the Placement and delivery of the Placement Agent Securities. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 11</u>. <u>NOTICES</u>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><u>SECTION 12</u>. <u>Press Announcements</u>. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference the Placement and the Placement Agent&#8217;s role in connection therewith in the Placement Agent&#8217;s marketing materials and on its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">[<em>The remainder of this page has been intentionally left blank.</em>]</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Please confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="margin:0px">Very truly yours,</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:50%;"></td> <td style="width:3%;"></td> <td style="width:35%;"></td> <td style="width:12%;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td colspan="2" style="vertical-align:top;"> <p style="margin:0px"><strong>A.G.P./ALLIANCE GLOBAL PARTNERS</strong></p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">By: </p></td> <td style="BORDER-BOTTOM: 1px solid;"><em>&nbsp;/s/ Thomas J. Higgins</em></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">Name:</p></td> <td style="vertical-align:top;"> <p style="margin:0px">&nbsp;Thomas J. Higgins</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">Title:</p></td> <td style="vertical-align:top;"> <p style="margin:0px">Managing Director</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"></td> <td style="width:50%;vertical-align:top;"> <p style="margin:0px"><u>Address for notice:</u></p> <p style="margin:0px">590 Madison Avenue, 28th Floor</p> <p style="margin:0px">New York, New York 10022</p> <p style="margin:0px">Attn: Thomas J. Higgins</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accepted and Agreed to as of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the date first written above:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="2" style="vertical-align:top;"> <p style="margin:0px"><strong>Upexi, Inc.</strong></p></td> <td></td></tr> <tr style="height:15px"> <td style="width:5%;"></td> <td style="width:45%;"></td> <td style="width:50%;"></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="margin:0px">By: </p></td> <td style="BORDER-BOTTOM: 1px solid;"><em>&nbsp;/s/ Allan Marshall</em></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="margin:0px">Name:</p></td> <td style="vertical-align:top;"> <p style="margin:0px">&nbsp;Allan Marshall</p></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="margin:0px">Title:</p></td> <td style="vertical-align:top;"> <p style="margin:0px">President and CEO</p></td> <td></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Address for notice</u>:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi, Inc.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Attn: Allan Marshall, President and CEO</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">3030 North Rocky Point Drive</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Tampa, Florida 33607</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">[<em>Signature Page to Placement Agency Agreement</em>]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>upxi_ex103.htm
<DESCRIPTION>LOCK-UP AGREEMENT
<TEXT>
<html><head><title>upxi_ex103.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.3</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><u>Form of Lock-Up Agreement</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:right;">[&#8226;], 2025</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">A.G.P./Alliance Global Partners</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">590 Madison Avenue, 28<sup style="vertical-align:super">th</sup>&nbsp;Floor</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">New York, New York 10022</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Re: </strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Upexi, Inc., Proposed Private Placement</strong></p></td></tr></table></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Ladies and Gentlemen:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The undersigned understands that you (&#8220;<strong><em>AGP</em></strong>&#8221;) propose to enter into a Placement Agency Agreement (the &#8220;<strong><em>Placement Agency Agreement</em></strong>&#8221;) providing for the offer and sale (the &#8220;<strong><em>Offering</em></strong>&#8221;) of (i) shares (the &#8220;<strong><em>Shares</em></strong>&#8221;) of common stock, par value $0.00001 per share (the &#8220;<strong><em>Common Stock</em></strong>&#8221;), of Upexi, Inc., a Delaware corporation (the &#8220;<strong><em>Company</em></strong>&#8221;) and (ii) warrants to purchase shares of Common Stock (the &#8220;<strong><em>Common Warrants</em></strong>&#8221;, and together with the Shares, the &#8220;<strong><em>Securities</em></strong>&#8221;). Capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement between the Company and the and the purchasers listed therein.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">In consideration of the execution of the Placement Agency Agreement by AGP, and for other good and valuable consideration, the undersigned hereby irrevocably agrees that, without the prior written consent of AGP, the undersigned will not, directly or indirectly, (a) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction or device that is designed to, or could reasonably be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of Common Stock (including, without limitation, (i) shares of Common Stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and over which the undersigned exercises investment discretion and (ii) shares of Common Stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for Common Stock; (b) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of Common Stock, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise; (c) except as provided for below, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common Stock or any other securities of the Company; or (d) publicly disclose the intention to do any of the foregoing for a period commencing on the date hereof and ending twenty (20) days following the Closing Date (such 20-day period, the &#8220;<strong><em>Lock-Up Period</em></strong>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0px;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The foregoing paragraph shall not apply to (a) transactions relating to shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock, or any other securities acquired in the open market after the completion of the Offering,&nbsp;<em>provided that</em>&nbsp;no filing under Section 16(a) of the Securities Exchange Act of 1934, as amended (the &#8220;<strong><em>Exchange Act</em></strong>&#8221;), shall be required or shall be voluntarily made in connection with such transactions; (b) bona fide gifts of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock, in each case that are made exclusively between and among the undersigned or members of the undersigned&#8217;s family, or affiliates of the undersigned, including its partners (if a partnership) or members (if a limited liability company) or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or as part of a distribution, transfer or disposition to its members, partners, shareholders or other equity holders of the undersigned; (c) any transfer of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock by will or intestate succession upon the death of the undersigned; (d) transfer of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock to an immediate family member (for purposes of this lock-up letter agreement (this &#8220;<strong><em>Lock-Up Letter Agreement</em></strong>&#8221;), &#8220;<strong>immediate family</strong>&#8221; shall mean any relationship by blood, marriage or adoption, not more remote than first cousin) or any trust, limited partnership, limited liability company or other entity for the direct or indirect benefit of the undersigned or any immediate family member of the undersigned;&nbsp;<em>provided&nbsp;</em>that, in the case of clauses (b), (c) and (d) above, it shall be a condition to any such transfer that (i) the transferee/donee agrees to be bound by the terms of this Lock-Up Letter Agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee/donee were a party hereto; (ii) each party (donor, donee, transferor or transferee) shall agree to not voluntarily make, any filing or public announcement of the transfer or disposition prior to the expiration of the Lock-Up Period referred to above and if any filing under Section 16(a) of the Exchange Act, or other public filing, report, or announcement reporting a change of beneficial ownership of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock in connection with such transfer or distribution, shall be legally required during the Lock-Up Period, such filing, report or announcement shall clearly indicate in the footnotes thereto the nature and conditions of such transfer; and (iii) except in the case of the death of the undersigned, the undersigned notifies AGP at least two (2) business days prior to the proposed transfer or disposition; (e) the transfer of shares to cover the applicable exercise price or tax withholding obligations, including estimated taxes, for any equity award granted pursuant to the terms of the Company&#8217;s stock option/incentive plans, such as upon exercise, vesting, lapse of substantial risk of forfeiture, or upon the exercise of warrants to purchase shares of Common Stock, or other similar taxable event, in each case on a &#8220;cashless&#8221; or &#8220;net exercise&#8221; basis ,&nbsp;<em>provided</em>&nbsp;that as a condition of any transfer pursuant to this clause (e), that if the undersigned is required to file a report under Section 16(a) of the Exchange Act or other public filing, report, or announcement, reporting a reduction in beneficial ownership of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock during the Lock-Up Period, the undersigned shall include a statement in such report, and if applicable an appropriate disposition transaction code, to the effect that such transfer is being made as a share delivery or forfeiture in connection with a net value exercise, or as a forfeiture or sale of shares solely to cover required exercise price or tax withholding obligations, including estimated taxes, as the case may be; (f) transfers of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock pursuant to a bona fide third party tender offer made to all holders of the Common Stock, merger, consolidation or other similar transaction involving a change of control (as defined below) of the Company, including voting in favor of any such transaction or taking any other action in connection with such transaction,&nbsp;<em>provided</em>&nbsp;that in the event that such merger, tender offer or other transaction is not completed, the Common Stock and any securities convertible into or exercisable or exchangeable for Common Stock shall remain subject to the restrictions set forth herein; (g) the vesting of equity awards, the exercise of warrants or the exercise of stock options granted pursuant to the Company&#8217;s stock option/incentive plans or otherwise outstanding on the date hereof;&nbsp;<em>provided</em>, that the restrictions shall apply to shares of Common Stock issued upon such vesting, exercise or conversion; (h) the establishment of any, or the continued use of any existing, contract, instruction or plan that satisfies all of the requirements of Rule 10b5-1 (a &#8220;<strong><em>Rule 10b5-1 Plan</em></strong>&#8221;) under the Exchange Act;&nbsp;<em>provided</em>,&nbsp;<em>however</em>, that except for already existing plans, no sales of Common Stock or securities convertible into, or exchangeable or exercisable for, Common Stock, shall be made pursuant to a Rule 10b5-1 Plan prior to the expiration of the Lock-Up Period;&nbsp;<em>provided further</em>, that the Company does not voluntarily effect any public filing or report regarding such Rule 10b5-1 Plan; (i) any demands or requests for, exercise any right with respect to, or take any action in preparation of, the registration by the Company under the Securities Act of the undersigned&#8217;s shares of Common Stock, provided that no transfer of the undersigned&#8217;s shares of Common Stock registered pursuant to the exercise of any such right and no registration statement shall be filed under the Securities Act with respect to any of the undersigned&#8217;s shares of Common Stock during the Lock-Up Period; (j) transfers of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock pursuant to an order of a court or regulatory agency (for purposes of this Lock-Up Letter Agreement, a &#8220;court or regulatory agency&#8221; means any domestic or foreign, federal, state or local government, including any political subdivision thereof, any governmental or quasi-governmental authority, department, agency or official, any court or administrative body, and any national securities exchange or similar self-regulatory body or organization, in each case of competent jurisdiction);&nbsp;<em>provided</em>&nbsp;that as a condition of any transfer pursuant to this clause; and, (j), that if the undersigned is required to file a report under Section 16(a) of the Exchange Act, or other public filing, report, or announcement reporting a reduction of beneficial ownership of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock in connection with such transfer, shall indicate, to the extent permitted by such section and related rules and regulations and by such order, that such transfer is pursuant to an order of a court or regulatory agency. For purposes of clause (f) above, &#8220;<strong>change of control</strong>&#8221; shall mean the consummation of any bona fide third party tender offer, merger, purchase, consolidation or other similar transaction the result of which is that any &#8220;<strong>person</strong>&#8221; (as defined in Section 13(d)(3) of the Exchange Act), or group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of a majority of total voting power of the voting stock of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0px;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#8217;s transfer agent and registrar against the transfer of the undersigned&#8217;s securities subject to this Lock-Up Letter Agreement except in compliance with this Lock-Up Letter Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">It is understood that, if the Company notifies AGP that it does not intend to proceed with the Offering, if the Placement Agency Agreement does not become effective, or if the Placement Agency Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Shares, the undersigned will be released from its obligations under this Lock-Up Letter Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The undersigned understands that the Company and AGP will proceed with the Offering in reliance on this Lock-Up Letter Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">This Lock-Up Letter Agreement shall automatically terminate upon (a) the termination of the Placement Agency Agreement prior to the issuance and delivery of the Shares, (b) the date that either the Company or AGP provides written notice to the other that it has determined not to proceed with the proposed Offering, provided that the Company and AGP shall not have executed the Placement Agency Agreement on or prior to such date. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">This Lock-Up Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof that would result in the application of the law of any other jurisdiction. Delivery of a signed copy of this Lock-Up Letter Agreement by facsimile or e-mail/.pdf transmission shall be effective as the delivery of the original hereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Letter Agreement and that, upon request, the undersigned will execute any additional documents necessary in connection with the enforcement hereof. Any obligations of the undersigned shall be binding upon the heirs, personal representative, successors and assigns of the undersigned.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">[<em>Signature page follows</em>]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp; </p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0px;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Very truly yours,</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(Name)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(Signature)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(Name of Signatory, in the case of entities &#8211;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Please Print)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(Title of Signatory, in the case of entities &#8211;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Please Print)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:53%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:5%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:10%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Address:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0px;">4</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>upxi_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>upxi_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="MARGIN: 0px; text-align:right;">&nbsp; <strong style='FONT-SIZE: 13px; FONT-FAMILY: "times new roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT-STYLE: normal; TEXT-ALIGN: right; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>EXHIBIT 99.1&nbsp;</strong></p> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><font style="font-size:14pt">Upexi, Inc. Announces Pricing of up to $23 Million Private Placement Offering of Common Stock and Warrants Priced above the At-the-Market Price under Nasdaq Rules</font></strong></p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><em>$10 Million Upfront with up to an Additional $13 Million of Aggregate Gross Proceeds Upon the Cash Exercise in Full of Warrants</em></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in">TAMPA, FL / Access Newswire / November 26, 2025 / Upexi, Inc. (NASDAQ: UPXI) (the "Company" or "Upexi"), &nbsp;a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it has entered into a securities purchase agreement with a single institutional investor, for the purchase and sale of 3,289,474 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 3,289,474 shares of common stock at a combined purchase price of $3.04, &nbsp;in a private placement offering priced above the at-the-market price under Nasdaq Stock Market LLC rules (the &#8220;Offering&#8221;). The warrants will have an exercise price of $4.00, will be immediately exercisable, and will expire 48 months from issuance. The $3.04 purchase price represents a 1.3x premium to the Company&#8217;s NAV using the Company's fully-loaded mNAV calculation, and is accretive to the Company's adjusted Solana (SOL) per share.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in">The closing of the Offering is expected to occur on or about December 1, 2025, subject to the satisfaction of customary closing conditions. The Company expects to receive gross proceeds of approximately $10 million from the Offering, and up to an additional $13 million following the cash exercise of the warrants, before deducting placement agent fees and other estimated offering expenses payable by the Company. The Company expects to use the net proceeds from the Offering for working capital, general corporate purposes and internally managed, SOL maximum return strategy.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in">A.G.P./Alliance Global Partners is acting as the sole placement agent in connection with the Offering.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in">The offer and sale of the foregoing securities are being made in a transaction not involving a public offering, and the securities have not been and will not initially be registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to the terms of the securities purchase agreement entered into with the investor, the Company agreed to file a registration statement with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) covering the resale of the shares of common stock issued or underlying common warrants issued to the investors no later than 5 calendar days after the closing of the offering and to use commercially reasonable efforts to have the registration statement declared effective within 60 days following the closing of the offering.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="text-align:center;margin:0px">1</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in"><strong>About Upexi, Inc.:</strong></p> <p style="margin:0px 0px 0px 0in">Upexi, Inc. (Nasdaq: UPXI) is a leading digital asset treasury company, where it aims to acquire and hold as much SOL as possible in a disciplined and accretive fashion. In addition to benefiting from the potential price appreciation of Solana - the cryptocurrency of the leading high-performance blockchain - Upexi utilizes three key value accrual mechanisms in intelligent capital issuance, staking, and discounted locked token purchases. The Company operates in a risk-prudent fashion to position itself for any market environment and to appeal to investors of all kinds, and it currently holds over two million SOL. Upexi also continues to be a brand owner specializing in the development, manufacturing, and distribution of consumer products. Please see www.upexi.com for more information.</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in">Follow Upexi on X - https://x.com/upexitreasury</p> <p style="margin:0px 0px 0px 0in">Follow CEO, Allan Marshall, on X - https://x.com/upexiallan</p> <p style="margin:0px">Follow CSO, Brian Rudick, on X - https://x.com/thetinyant</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in"><strong>FORWARD LOOKING STATEMENTS:</strong></p> <p style="margin:0px 0px 0px 0in">This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. For example, the Company is using forward looking statements when it discusses the expected closing of the Offering and the anticipated use of proceeds. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with business strategy, potential acquisitions, revenue guidance, product development, integration, and synergies of acquiring companies and personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward- looking statements. Although we believe that the beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K and other periodic reports filed from time-to-time with the Securities and Exchange Commission. </p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="text-align:center;margin:0px">2</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in"><strong>Company Contact</strong></p> <p style="margin:0px 0px 0px 0in">Brian Rudick, Chief Strategy Officer</p> <p style="margin:0px 0px 0px 0in">Email:brian.rudick@upexi.com</p> <p style="margin:0px 0px 0px 0in">Phone: (203) 442-5391</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in"><strong>Investor Relations Contact</strong></p> <p style="margin:0px 0px 0px 0in">KCSA Strategic Communications</p> <p style="margin:0px">Valter Pinto or Jack Perkins</p> <p style="margin:0px">Email:&nbsp;Upexi@KCSA.com</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px 0px 0px 0in"><strong>Media Relations Inquiries</strong></p> <p style="margin:0px 0px 0px 0in">Greg or Katie @STiR-communications.com</p> <p style="margin:0px 0px 0px 0in">STiR-communications.com</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px 0px 0px 0in">SOURCE:&nbsp;Upexi&nbsp; </p> <p style="margin:0px 0px 0px 0in">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="text-align:center;margin:0px">3</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>upxi-20251126.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/02/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-types="http://fasb.org/us-types/2025" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:cyd="http://xbrl.sec.gov/cyd-af-sub/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:upxi="http://upxi.com/20251126" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://upxi.com/20251126">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://upxi.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="upxi-20251126_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="upxi-20251126_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="upxi-20251126_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="upxi-20251126_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
 <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
 <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
 <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>upxi-20251126_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/02/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>upxi-20251126_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/02/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://upxi.com/role/Cover" xlink:href="upxi-20251126.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://upxi.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>upxi-20251126_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/02/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://upxi.com/role/Cover" xlink:href="upxi-20251126.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://upxi.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>upxi-20251126_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/02/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://upxi.com/role/Cover" xlink:href="upxi-20251126.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://upxi.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UPEXI, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001775194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 26,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-3378978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">3030 N. Rocky Point Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Tampa<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">33607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">353-5425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UPXI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="upxi_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://upxi.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>upxi-20251126.xsd</File>
    <File>upxi-20251126_cal.xml</File>
    <File>upxi-20251126_def.xml</File>
    <File>upxi-20251126_lab.xml</File>
    <File>upxi-20251126_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="upxi_8k.htm">upxi_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "upxi_8k.htm": {
   "nsprefix": "upxi",
   "nsuri": "http://upxi.com/20251126",
   "dts": {
    "schema": {
     "local": [
      "upxi-20251126.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "upxi-20251126_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "upxi-20251126_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "upxi-20251126_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "upxi-20251126_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "upxi_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://upxi.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-11-26to2025-11-26",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-11-26to2025-11-26",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001477932-25-008713-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-25-008713-xbrl.zip
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M!BL[@V?<[!Y2PX='Q<S!5WYFK$%9(_0Z@[)R,8B4:]FV%C)C?2EH>69JP%H
ME=1M4U*::LJAED>$FCZ8?6,VG*$[&%663$A9<P)@J+G@Z?H'XH"@DI&2('@'
MCN#N$0\R;$R[:5>U[Z@JF)*P.4<PU(!DWP($@XLC5Z6+&CZ*6O!@J(>;[ YE
M-@./B+5%!,'PVD'E_O\BY/J!1CB-H0@I_S_%,8N8V:LTIJ;CUP 5L\9R2?4S
M7E.58$+/.(,^B::8<Z%M?S=#&"<)XY&P S0U^VUB6L4WF"-D/OZ>/YY*VF9R
M+^ L<Q"#2F2?F48N$M*(<6;]#,Q?@-S#X>4BRYCZQ]"J0@H'U5_\QG[#$:*
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M&O/AD=>I,1=P\W'D<>IG"C?? 5!+ P04    " ! AH%;X5F.2-H!  "+ P
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MN 4V$T3Q$'U'4^L,XZY5DFR*,NH_>,RFB<UTZ)[QA'.-[AQLYT]02P,$%
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M+'_ CS$M*'Z-+.,'/<?JO^=]?& L7ZF?#6:'</I3NNO_ 5!+ P04    " !
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MNQ9Q!3@8P>-YNE6$"UPPA EPP>#[P9\IF=>1VG*1)])]B0^[.A_A/KK!56^
MDWGU.ZR;$!])G1A'WAC76#LKY-W1/<$6J]D>*IR0QAZ05ADY*\D>]I[:##YR
MFE6C?"5Q8GGA@66E%0_'_ET.*L,+G-^47)IY7^8+*AI7@)H )]"_>%L'&FUZ
M60V&H)A,[T1JKU.;EX574B?4;SRN#Y76/,SMCXS#8Y%/OUQZ54WHERHGM&^]
MS>)C0QZH8N4BU4*J$LL8Z4!?%GB67?=EVGAY=B+0B?VOWM@[V?8P'!.Z&J1H
MD,W8IA0[/>-K0YR&X)VW(3AAU0/\7IHB)+W]P H1HB;PE7(GZ)?>H#=8_%\
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MU9^.T[8L\,;NF*)L6YZ$4Z_]_U!+ P04    " ! AH%;*Z>#L&^8  #F]P(
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M)]F+ []<[K;XD"X\.WG^XM4+7)2S#VKG%G?-T<%1!L?[63FO:I8O>+8/X#Z
MM6.)$PJC&3X)>Z5<=.4U+F1JU^".@;.(QVW5='JBPF>P25Y+E/C<^&5Q5?(F
M+8L:/DX).Q5IT/-=]\ G.6_F"I[^L:Y:',4;N%2:VEY&W27.0SPNV,<B0V!N
MX:*[I/'C$)W /GARIS>2'1UVZ#;&].C@:._WN[UHS;#F\VI1P9UD1X9#P?MV
M(RL)XRM@J\[@^IC"59+!MJYJ]U=_V3;KBTM0;DK\ANZ("H_HLIQ510LW24["
MM6T6'?VTTS]!YF63C7Q&MR%\LUS""^6![+J"+5](-^AB=E/:D0Q==RRP13D
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MP.RCT0'=+)>K1;,I]2GL"ZX 3V]7+2L8('P(!Z3C?L(1JJ:L8C=\:+"':*S
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M'4B/PN@)7S?OHUO[^F703F($.THVH4<@YH.C'7:#/)?>#F,[X*\5@E=:56T
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MY225 I(-+1[1;FI!6J="V")^+R(G=H'Z6EQLT:6TMN6\I'1^A[8["[:(R\^
MKY:Z*9+\+$9.5!UFQ;1W78 /W5%P2%[;O&*<V?]D_\G4I3^$>],!KC6[P$Y(
MU9D2BQ1BBHM;^-,A"<UH'^C.*-]AF4I)P=4<7[?=/*G=HKAVY_-W6-IN5CE)
MQP4I3=$->JL99.[]9^1FZ"HL3=]<2VA8-7F*7L)!I \QVH<-K[C47:69/5AN
M4S)#&ZEPVK"Z[6@;8(-)_A8G<\W6F,%\  8$&QAV-]:RH<S!H8*4V575B&F
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M.L(^@HC4Y%AN2]SNZ)^PG)2[C"J-D1H=FD3##=AE")")H$8%*S5.A&VB?<A
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MX0JD]IT<9Z]>;3GL062R1RS&@+-MT'Y!54>3D*!?#\X.1G*[Q$]-#%RI1->
M_<%,$CGN_9_JC4-',^5?%&'Y;(?)=C^^+B[$-WB)'K\;2;;"H;D\UYRH%*]
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MJ=S3]>4@I]>[$']VO],-&(*;*/LDFLH\B#4.R*A@&=88YB#93&[?KJ/0F0V
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MB 09=3D*A\\9&H>PVW'AQ$L1IR *?J]IP]HX/:-CT2ORIZ\^4]35RA089!B
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M%)I[4V4\<5N!U.2J3!1HHA@/67[3WK\M I)R!8^Q/L4UD@L4T0\\"[33C1@
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M,\GN(;10G+_C]C#%0&(QP(X%!(AEQ9*4:===,D_?42;V>"H(TQZ[1 O0BN"
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MN:)GB6FNPS1--[1A6F^O"0F4S=YS8."D%"-! .=\:YA"<KEP&L$QD2WV%7I
M_'2A1Y,C? )1$UFV;+CY0C^M5CH&(%!:!/C;%W59P>8]W3_<B7:#:]A<YN>M
M1MY3?#SQX@,M<^.S*Q(>_) G.&$M ["6(#^A"71$ W\N!+ Z/$::F+]037C)
M<&REUWV6+:"KQ_ Z7V)O;(T-&GD-D46DBX6:&6*03X> A]QT]!PNY!R9[1S
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M.'-<'&0]OC#'H\0]Q2X.#NL"FL1:Q^)0#;)4J+QECI <0SRE:)\@>5!TG'#
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MGZ^"*]WW-M5N"_+RVP>7[CT: K[/<_EO4$L#!!0    ( $"&@5M^,-\D8@T
M )4H   .    =7!X:5]E>#DY,2YH=&WM6N]3&T<2_5?F=,[95$E" AS'@E"1
M01#.@#A)CIW[<C7:'4EC=G<V,[L(Y:^_USV[JQ4&;!+JOEPJ%8-VYT?/Z^[7
MKT<<++(X.CQ8*!D>'F0ZB]1AGM[J_ZC;MV^[;;P\V/9/#_[6:AV;((]5DHG
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M4$L! A0#%     @ 0(:!6QLB<I3&%@  Y9$   L              ( !8A0
M '5P>&E?.&LN:'1M4$L! A0#%     @ 0(:!6RNG@[!OF   YO<"  X
M         ( !42L  '5P>&E?97@Q,#$N:'1M4$L! A0#%     @ 0(:!6Y0)
MAO4Z(@  SYT   X              ( ![,,  '5P>&E?97@Q,#(N:'1M4$L!
M A0#%     @ 0(:!6]0!*Y]C$P  7VD   X              ( !4N8  '5P
M>&E?97@Q,#,N:'1M4$L! A0#%     @ 0(:!6WXPWR1B#0  E2@   X
M         ( !X?D  '5P>&E?97@Y.3$N:'1M4$L%!@     *  H = (  &\'
$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>upxi_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="upxi-20251126.xsd" xlink:type="simple"/>
    <context id="From2025-11-26to2025-11-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001775194</identifier>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2025-11-26to2025-11-26" id="ixv-406">0001775194</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2025-11-26to2025-11-26" id="ixv-407">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2025-11-26to2025-11-26" id="ixv-427">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2025-11-26to2025-11-26" id="ixv-428">2025-11-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2025-11-26to2025-11-26" id="ixv-429">UPEXI, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-11-26to2025-11-26" id="ixv-430">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2025-11-26to2025-11-26" id="ixv-431">001-40535</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-11-26to2025-11-26" id="ixv-432">83-3378978</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-11-26to2025-11-26" id="ixv-433">3030 N. Rocky Point Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-11-26to2025-11-26" id="ixv-434">Suite 240</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-11-26to2025-11-26" id="ixv-435">Tampa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-11-26to2025-11-26" id="ixv-436">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-11-26to2025-11-26" id="ixv-437">33607</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-11-26to2025-11-26" id="ixv-438">701</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-11-26to2025-11-26" id="ixv-439">353-5425</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2025-11-26to2025-11-26" id="ixv-440">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2025-11-26to2025-11-26" id="ixv-441">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2025-11-26to2025-11-26" id="ixv-442">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2025-11-26to2025-11-26" id="ixv-443">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2025-11-26to2025-11-26" id="ixv-444">Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2025-11-26to2025-11-26" id="ixv-445">UPXI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2025-11-26to2025-11-26" id="ixv-446">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-11-26to2025-11-26" id="ixv-447">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
